Viome Life Sciences raises $67M and more digital health fundings

Viome Daily life Sciences declared it experienced lifted $67 million in Series C funding led by Bold Capital Team.

The new funding, which involved participation from present traders Khosla Ventures, West River Team, Glico, Ocgrow Ventures and Medical doctor Companions, delivers the firm’s increase to extra than $150 million.

Viome presents gut microbiome exams for shoppers and presents nourishment recommendations dependent on results. It also acquired Fda Breakthrough Gadget Designation past year for its mRNA analysis technology and synthetic intelligence system that aims to detect early indicators of oral and throat cancers. The Breakthrough Equipment system just isn’t a advertising and marketing authorization from the Fda, though the aim is to pace the progress and evaluation of merchandise to deal with or diagnose lifetime-threatening or debilitating ailments or circumstances.

Viome options to use the funds to start a new line of exams targeted on the oral microbiome. The business raised $54 million previous calendar year and expanded its partnership with GlaxoSmithKline to study and perhaps create interventions for some cancers and autoimmune disorders.

Genomic tests business Variantyx brought in $20 million in credit card debt financing from Kreos Money.

The startup gives genomic tests and analytics for exceptional genetic conditions, reproductive wellness and precision oncology. Earlier this calendar year, Variantyx declared a $41.5 million C-2 funding round.

“Variantyx has developed a unique and highly developed platform for precision drugs and its capacity to course of action the whole genome sets it apart in the genomic diagnostics industry. Our resources, which increase the company’s already strong money posture, will let it to drastically scale up its commercial efforts,” Aris Constantinides, basic lover of Kreos Cash, said in a statement.

In-man or woman and digital psychological overall health provider Aware Treatment scooped up $7 million in a Series B round led by Sopris Money.

Others taking part in the elevate consist of the University of Chicago, the Caruso Basis and the Venkon Group. The startup declared a $2.7 million Collection A a calendar year ago and a $1.5 million good friends and spouse and children spherical in 2020.

Mindful Treatment will use the Series B to grow in regions including the Midwest and Southeast, start person treatment and addiction cure programs, and keep on to acquire its technology.

Rhino Health, which delivers a platform that lets researchers and health care AI builders to accessibility and collaborate around assorted datasets, declared a $6.7 million extension to its seed spherical very last week. 

Fusion Fund and LionBird Ventures co-led the round with participation from Qiming Enterprise Associates, Maccabi Health and fitness Solutions and Arkin Holdings.

The firm announced it had scooped up $5 million in February 2021. Rhino’s total funding pot now arrives to $11.7 million.  

“The Rhino Health System solves a true require in the healthcare AI industry — entry to greater, more numerous and evolving datasets. The progress we have manufactured with our partners so much presents us great self-confidence that distributed computing and federated finding out are a match-changer for health care,” cofounder and CTO Yuval Baror reported in a assertion. “Allowing for healthcare corporations to retain knowledge in just their data methods, when providing developers a distributed computing system to securely perform with this details, will accelerate the future wave of healthcare innovation.”

Telemedicine abortion clinic Hey Jane lifted $6.1 million in funding, bringing its total increase to $9.7 million.

The spherical bundled Ulu Ventures, The Helm, Amboy Road, Portfolia, G9, Social Starts off and Garden Ventures. The startup will use the funding to improve its crew, include new insurance provider and enterprise partnerships, extend to new states and include new healthcare services, like remedy for postpartum melancholy and stress.

Kyros, a platform that connects individuals with compound use disorder with vendors and other resources, elevated an additional $2.4 million in seed funding led by Rally Ventures, with participation from strategic angel investors.

The startup launched in Minnesota before this year and announced a $4.4 million seed elevate in July. Kyros designs to use the funding to go on acquiring its platform, broaden into new markets and retain the services of staffers.